Product Certification&
Enterprise Certification
Country: China (Mainland)
Business Type:Lab/Research institutions
Tel: +86-871-65110906
Mobile: 86-131 6530761
Tel: +86-871-65110906
Fax:
Province/state: Yunnan
City: Kunming
Street: Room702, Building 2, 365 Dianchi Road, Kunming, Yunnan Province, P.R. China
MaxCard:
CAS NO.37758-47-7
MONOSIALOGANGLIOSIDE(37758-47-7)
Information
The pharmacological mechanism of monosialoganglioside is to promote neural remodeling. It can improve the activity of nerve cell membranes, thereby reducing nerve cell edema and promoting the growth of nerve cell axons and synapses. Therefore, it can be used clinically to treat cerebrovascular diseases or central nervous system damage caused by brain trauma. It has a good recovery effect on paralysis caused by central nervous system damage, speech dysfunction and other symptoms. It can also be used to treat Parkinson's disease.
Treat nerve damage, neuropathy, neurological disorders. Brain-protecting drugs, nourish brain nerves, promote brain cell metabolism. It is used to treat hypoxia, ischemic encephalopathy, nerve damage of various traumatic and cardiovascular and cerebrovascular diseases, neonatal jaundice, neonatal hypoxia, ischemia, and neurological dysfunction in the late stage of various chronic diseases (such as the limbs in the late stage of diabetes Numbness), brain atrophy, Alzheimer's, intellectual disability, Parkinson's disease.
Quality
Advanced technology
Supper quality
Effective & safety package
Service
Professional and timely afte-sale service(replied within 12h)
COMPANY INFORMATION
Jinan Kangcheng Pharmaceutical Technology Co., Ltd.
Add:Jinan Area,China(Shandong) Pilot Free Trade Zone,China
The company focuses on the development and transfer of pharmaceutical technology. It is a modern enterprise integrating technology development, transfer and sales of APIs, pharmaceutical intermediates, and nutraceutical raw materials.
The company adheres to the principle of integrity and innovation, and provides customers with professional products and advanced technical services.
MONOSIALOGANGLIOSIDE |
|
Product information |
English Name:Monosialoganglioside |
English Alias:Sygen;Ganglioside M1;GM1; Monosialotetrahexosylganglioside Sodium; Ganglioside GM1 (Ovine Brain) |
|
Chinese Name:单唾液神经节苷脂 |
|
Chinese Name:单唾液酸神经节苷酯GM1; 神经节苷酯 M1; 单唾液神经节苷酯(-20℃); 单唾液酸四己糖神经节苷脂 |
|
CAS:37758-47-7 |
|
Formula:C73H131N3O31 |
|
Molecular weight:1563.85 |
|
|
|
Appearane:White or off-white crystalline power |
|
Purity:99.0% |
|
Use&Pharmacology |
Gangliosides have a significant effect on nerve regeneration. Single salivary gangliosides can promote the recovery of nerve function after central nervous system damage caused by various reasons. The mechanism of action is to promote nerve remodeling (including the survival of nerve cells, axis Synapse growth and synapse production). It has a protective effect on secondary neurodegeneration after injury, can improve cerebral hemodynamic parameters and reduce brain edema after injury, and can also improve behavioral disorders caused by Parkinson's disease. |
Dosage |
20-40mg a day, once or divided intramuscularly or slowly intravenously. In the acute phase of the disease (especially acute trauma), 100 mg daily, intravenous drip, 2 to 3 weeks later, change to maintenance dose, 20 to 40 mg daily, usually 6 weeks。 |
Adverse reactions |
The adverse reaction of single salivary ganglioside is mainly a rash reaction after use. |
Package&Storage |
Package:1kg/bag, 10kg/drum, 25kg/drum (on request) |
Storage&Validity:Cool, shading, dry and sealed/2years |